Hydrogen sulphide-generating pathways in haemodialysis patients: A study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes

Nephrology Dialysis Transplantation

Volumn 24, Issue 12, 2009, Pages 3756-3763

  Perna, Alessandra F ^a   Luciano, Maria Grazia ^a   Ingrosso, Diego ^b   Pulzella, Paola ^a   Sepe, Immacolata ^a   Lanza, Diana ^a   Violetti, Eleonora ^a   Capasso, Rosanna ^b   Lombardi, Cinzia ^a   De Santo, Natale G ^a  

^a Department of Clinical and Experimental Internal Medicine ^*  (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cystathionine synthase; Cystathionine lyase; Haemodialysis; Homocysteine; Hydrogen sulphide

Indexed keywords

CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; CYSTEINE; HOMOCYSTEINE; HYDROGEN SULFIDE; PYRIDOXINE; SULFHEMOGLOBIN; SULFUR AMINO ACID; VITAMIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; DOWN REGULATION; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPECTROPHOTOMETRY; TRANSCRIPTION REGULATION; UREMIA;

ADULT; AGED; FEMALE; HUMANS; HYDROGEN SULFIDE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TRANSCRIPTION, GENETIC;

EID: 71049167707     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp378     Document Type: Article

References (47)

1. Lefer DJ. A new gaseous signaling molecule emerges: cardioprotec-tive role of hydrogen sulfide. Proc Natl Acad Sci USA 2007; 104: 17907-17908
2. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935
3. Wang R. Is H2S a stinky remedy for atherosclerosis? Arterioscler Thromb Vasc Biol 2009; 29: 156-157
4. Kamoun P. Endogenous production of hydrogen sulfide in mammals. Amino Acids 2004; 26: 243-254
5. Yang G, Wu L, Jiang B et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590
6. Wang J, Dudman NP, Wilcken DE et al. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis 1992; 97: 97-106
7. Shibuya N, Tanaka M, Yoshida M et al. 3-mercaptopyruvate sulfur-transferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2008; 11: 703-714
8. Billaut-Laden I, Rat E, Allorge D et al. Evidence for a functional genetic polymorphism of the human mercaptopyruvate sulfurtrans-ferase (MPST), a cyanide detoxification enzyme. Toxicol Lett 2006; 165: 101-111 (Pubitemid 43914274)
9. Chen X, Jhee K, Kruger WD. Production of the neuromodulator H2S by cystathionine ß-synthase via the condensation of cysteine and ho-mocysteine. J Biol Chem 2004; 279: 52082-52086
10. Sokolowska M, Wlodek L, Srebro Z et al. The effect of nitrogen oxide level modulation on the content of thiol compounds and anaerobic sulfur metabolism in mice brains. Neurobiology 1999; 7: 461-477
11. Benavides GA, Squadrito GL, Mills RW et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci USA 2007; 104: 17977-17982
12. Zhao W, Zhang J, Lu Y et al. The vasorelaxant effect of H2S as a novel endogenous gaseous KAT P channel opener. EMBO J 2001; 20: 6008-6016
13. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27 (Pubitemid 37524019)
14. Jiang HL, Wu HC, Li ZL et al. Changes of the new gaseous transmitter H2S in patients with coronary heart disease. Di Yi Jun Yi Da Xue Bao 2005; 25: 951-954
15. Li C, Sumou I, Ya-guang D et al. Imbalance of endogenous homocys-teine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J 2007; 120: 389-393
16. Wang Y, Zhao X, Jin H et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2008; 29: 173-179
17. Jeney V, Komodi E, Nagy E et al. Suppression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H2S). Free Radic Biol Med 2009; 46: 616-623
18. D'Emanueledi Villa BiancaR, SorrentinoR,Maffia P et al. Hydrogen sulfide as a mediator of human corpus cavernosum smooth-muscle relaxation. Proc Natl Acad Sci USA 2009; 106: 4513-4518
19. Xu Z, Prathapasinghe G, Wu N et al. Ischemia-Reperfusion reduces cystathionine-beta-synthase mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol 2009; 279: F27-F35
20. Tangerman A.Measurement and biological significanceofthe volatile sulfur compounds hydrogen sulfide, methanethiol and dimethyl sul-fide in various biological matrices. J Chromatogr B 2009; (May 21) doi: 10.1016/jjchromb.2009. 05.026
21. Whiteman M, Moore PK. Hydrogen sulfide and the vasculature: a novel vasculoprotective entity and regulator of nitric oxide bioavail-ability? J Cell Mol Med 2009; 13: 488-507
22. Whitfield NL, Kreimier EL, Verdial FC et al. Reappraisal of H2S/sulfide concentration in vertebrate blood and its potential significance in ischemic preconditioning and vascular signaling. Am J Physiol Regul Integr Comp Physiol 2008; 294: R1930-R1937
23. Furne J, Saeed A, Levitt MD. Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1479-R1485
24. Richardson CJ, Magee EAM, Cummings JH. A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 2000; 293: 115-125
25. Stenvinkel P, Carrero JJ, Axelsson J et al. Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 2008; 3: 505-521
26. Ingrosso D, Cimmino A, Perna AF et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 2003; 361: 1693-1699
27. Perna AF, Ingrosso D, De Santo NG et al. Mechanism of erythro-cyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia. Kidney Int 1995; 47: 247-253
28. Van Guldener C, Stehouwer CD. Homocysteine and methionine metabolism in renal failure. Semin Vasc Med 2005; 5: 201-208
29. Massy ZA, Borderie D, Nguyen-Khoa T et al. Increased plasma S-nitrosothiol levels in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 153-157 (Pubitemid 36104492)
30. Nakanishi T, Hasuike Y, Otaki Y et al. Free cysteine is increased in plasma from hemodialysis patients. Kidney Int 2003; 63: 1137-1140
31. Kamoun P, Belardinelli M, Chabli A et al. Endogenous hydrogen sulfide overproduction in Down syndrome. Am J Med Genet 2003; 116A: 310-311
32. Łowicka E, Bełtowski J. Hydrogen sulfide (H2S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007 1 4-24.
33. Casas JP, Bautista L, Smeeth L et al. Homocysteine and stroke: evidence on a causal link from Mendelian randomization. Lancet 2005; 365: 224-232
34. Chunyu Z, Junbao D, Dingfang B et al. The regulatory effect of hydrogen sulfide onhypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816
35. Siggaard-Andersen O, Nørgaard-Pedersen B, Rem J. Hemoglobin pigments, spectrophotometric determination of oxy-, carboxy-, met-, and sulfhemoglobin in capillary blood. Clin Chim Acta 1972; 42: 85-100
36. Perna AF, Satta E, Acanfora F et al. Increased plasma protein homo-cysteinylation in hemodialysis patients. Kidney Int 2006; 69: 869-876
37. Ponchel F, Toomes C, Bransfield K et al. Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletion. BMC Biotechnol 2003; 13: 3-18
38. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Nor-walk: Appleton & Lange, 1990
39. PrudovaA,Bauman Z, Braun Aet al. S-adenosylmethionine stabilizes cystathionine ß-synthase and modulates redox capacity. Proc Natl Acad Sci USA 2006; 103: 6489-6494
40. Perna AF, Ingrosso D, De Santo NG. MTHFR C677T polymorphism and skin color: the white man's blackness. Kidney Int 2004; 65: 2444
41. Singh S, Padovani D, Leslie RA et al. The relative contributions of cystathionine beta-synthase and gamma-cystathionase to H2S biogenesis via alternative transsulfuration reactions. J Biol Chem 2009; in press (doi:10.1074/jbc.M109.010868)
42. Chiku T, Padovani D, Zhu W et al. H2S biogenesis by human cys-tathionine gamma-lyase leads to the novel sulfur metabolites lanthio-nine and homolanthionine and is responsive to the grade of hyperho-mocysteinemia. J Biol Chem 2009; 284: 11601-11612
43. Sun Q, Collins R, Huang S et al. Structural basis for the inhibition mechanism of human cystathionine-γ-lyase: an enzyme responsible for the production of H2S. J Biol Chem 2009; 284: 3076-3085
44. Hasuike Y, Nakanishi T, Moriguchi R et al. Accumulation of cyanide and thiocyanate in hemodialysis patients. Nephrol Dial Transplant 2004; 19: 1474-1479
45. Vanholder R, Argiles A, Baurmeister U et al. Uremic toxicity: present state of the art. Int J Artif Org 2001; 24: 695-725
46. Sen U, Basu P, Abe OA et al. Hydrogen sulfide ameliorates hyper-homocysteinemia associated chronic renal failure. Am J Physiol Ren Physiol 2009; (May 27). doi: 10.1152/ajprenal.00145.2009
47. Zoccali C, Catalano C, Rastelli S. Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage. Nephrol Dial Transplant 2009; 24: 1396-1396